Top Suppliers:I want be here
Related CAS#:
129-17-9 116-95-0
133978-89-9 3536-49-0
20262-76-4 3486-30-4
86280-78-6 36505-52-9
6059-34-3 114567-73-6
1158522-08-7 940364-43-2
134104-43-1 131615-57-1
6906-52-1 930439-75-1
2231426-63-2 1018584-77-4
1375289-11-4 849349-65-1

129-17-9

129-17-9 structure
129-17-9 structure
  • Name: patent blue violet
  • Chemical Name: Patent Blue VF
  • CAS Number: 129-17-9
  • Molecular Formula: C27H31N2NaO6S2
  • Molecular Weight: 566.665
  • Catalog: Dyes and pigments dye Acid Dyestuff
  • Create Date: 2018-05-29 08:00:00
  • Modify Date: 2024-01-02 14:25:14
  • Patent Blue V (Acid blue 1) is a novel biological dye that can be used as an intraocular dye for retinectomy. Retinectomy refers to the removal of the translucent inner limiting membrane (ILM). The application of appropriate dyes in vitreoretinal surgery can achieve the purpose of complete removal. Patent Blue V can be used to stain retinal premembranous structures. Spectral analysis shows that Patent Blue V has strong absorption below 450 nm and above 600 nm, showing a blue-green color. Patent Blue V is also used as a marker in lymphangiography for resection of neoplastic lymph nodes[1][2].
Name Patent Blue VF
Synonyms sodium,4-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,3-disulfonate
Sodium 4-{[4-(diethylamino)phenyl][4-(diethyliminio)cyclohexa-2,5-dien-1-ylidene]methyl}benzene-1,3-disulfonate
Patent Blue VF,indicator grade
EINECS 204-934-1
Acid blue 1 sodium salt,Disulfin blue VN 150 sodium salt
Acid Blue 1 Sulfan Blue
ethanaminium, N-[4-[[4-(diethylamino)phenyl](2,4-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, inner salt, monosodium salt
Natrium-4-{[4-(diethylamino)phenyl][4-(diethyliminio)cyclohexa-2,5-dien-1-yliden]methyl}benzol-1,3-disulfonat
MFCD00012119
Ethanaminium, N-[4-[[4-(diethylamino)phenyl](2,4-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, inner salt, sodium salt (1:1)
patent blue violet
4-{[4-(diéthylamino)phényl][4-(diéthyliminio)cyclohexa-2,5-dién-1-ylidène]méthyl}benzène-1,3-disulfonate de sodium
Sodium 4-{[4-(diethylamino)phenyl][4-(diethyliminio)-2,5-cyclohexadien-1-ylidene]methyl}-1,3-benzenedisulfonate
Description Patent Blue V (Acid blue 1) is a novel biological dye that can be used as an intraocular dye for retinectomy. Retinectomy refers to the removal of the translucent inner limiting membrane (ILM). The application of appropriate dyes in vitreoretinal surgery can achieve the purpose of complete removal. Patent Blue V can be used to stain retinal premembranous structures. Spectral analysis shows that Patent Blue V has strong absorption below 450 nm and above 600 nm, showing a blue-green color. Patent Blue V is also used as a marker in lymphangiography for resection of neoplastic lymph nodes[1][2].
Related Catalog
References

[1]. Mennel S, et al. Patent blue: a novel vital dye in vitreoretinal surgery. Ophthalmologica. 2006;220(3):190-3.  

[2]. Barranger E, et al. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer. 2003 Jun 15;97(12):3003-9.  

Melting Point 290ºC
Molecular Formula C27H31N2NaO6S2
Molecular Weight 566.665
Exact Mass 566.152100
PSA 137.41000
LogP 5.92380
Stability Stable. Incompatible with strong oxidizing agents.
Water Solubility 1 g/20 mL (20 ºC)

CHEMICAL IDENTIFICATION

RTECS NUMBER :
BP6830000
CHEMICAL NAME :
Ammonium, (4-(alpha-(p-(diethylamino)phenyl)-2,4-disulfobenzyli dene)-2,5-cyclohexadi en-1- ylidene)diethyl-, hydroxide, monosodium salt
CAS REGISTRY NUMBER :
129-17-9
LAST UPDATED :
199701
DATA ITEMS CITED :
17
MOLECULAR FORMULA :
C27-H31-N2-O6-S2.Na
MOLECULAR WEIGHT :
566.71
WISWESSER LINE NOTATION :
L6Y DYJ AUYR DN2&2&R BSWO DSWQ& DUK2&2 &-NA- &35/25

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
33 ug/kg
TOXIC EFFECTS :
Immunological Including Allergic - anaphylaxis
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
110 mg/m3/13W-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3000 mg/kg/33W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2070 mg/kg/50W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Blood - lymphoma, including Hodgkin's disease Tumorigenic - tumors at site of application
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
4050 mg/kg/45W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
200 mg/kg
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 170,75,1986 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 16,163,1978 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 16,163,1978 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - T0027 No. of Facilities: 16 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 65 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - T0027 No. of Facilities: 5396 (estimated) No. of Industries: 45 No. of Occupations: 49 No. of Employees: 80939 (estimated) No. of Female Employees: 18204 (estimated)
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes T
Risk Phrases R45
Safety Phrases S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS BP6830000
HS Code 32041200
HS Code 32041200

Chemsrc provides CAS#:129-17-9 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 129-17-9 | Chemsrc address: https://m.chemsrc.com/en/baike/965521.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved